Vestnik On-line
Orenburg State University december 02, 2021   RU/EN
Headings of Vestnik
Pedagogics
Psychology
Other

Search
Vak
Антиплагиат
Orcid
Viniti
ЭБС Лань
Rsl
Лицензия Creative Commons

2014, № 12 (173)



Nikolaeva G.V., Sidorenko E.E., Sidorenko E.I. USE OF INHIBITOR OF A VASCULAR ENDOTELIAL FACTOR OF GROWTH AT AN ABNORMAL PROLIFERATIVE ANGIORETINOPATHY AT THE PREMATURE CHILDIn the article there was described the case of abnormal proliferative angioretinopathy in premature child of bihoreal biamniotic twins. Pregnancy is the result of in vitro fertilization. Childbirth is operational at time of 34 weeks gestation, the baby's weight at birth is 1920 grams. An inhibitor of VEGF was intravitreally injected once at a dose of 0,0125 ml per eye. Activity of blood vessels and vascular proliferation were successfully cropped.Key words: inhibitors of vascular endothelial growth factor; intravitreal injection; premature infants; proliferative angioretinopathia

Download
References:

1. Gorustovich, J. Features of the early neonatal period in children born as a result of IVF / J. Gorustovich, T.N. Wojtowicz, S.E. Efymenko // Medical News. — 2014. — №2 (233). — P. 62–64.

2. Katargina, L.A. Current status of retinopathy of prematurity and objectives for improving eye care for premature babies in the Russian Federation / L.A. Katargina // Retinopathy of Prematurity: Coll. scientific. works. — M., 2011 — P. 5–10.

3. Krasil'nikova, V.L. The use of angiogenesis inhibitors in treatment of the back of an aggressive form of retinopathy of prematurity / V.L. Krasil'nikova, K.U. Vilchuk, I.N. Smirnov // Ophthalmology Eastern Europe. — 2012. — №3. — P. 53–56.

4. Molchanova, E.V. Features state of the vision of children born through in vitro fertilization and embryo transfer / E.V. Molchanova // Russian pediatric ophthalmology. — 2007. — №4. — P. 31–34

5. Health of children born after IVF / G.M. Savelieva [et al.] // Obstetrics and gynecology. — 2010. — №5. — P. 49–54.

6. Risk factors and frequency of retinopathy in very preterm children in the use of modern perinatal technologies / E.I. Sidorenko [et al.] // Russian children ophthalmology. — 2012. — №3. — P. 5–9.

7. Analysis of the retinal vessels in the prediction of the flow of retinopathy of prematurity / A.V. Tereshchenko [et al.] // Ophthalmosurgery. — 2006. — 8. — №3. — P. 41–44.

8. Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity Revisited // Int. Arch. Ophthalmol. — 2005. — Vol. 123. — No. 7. — P. 991–999.

9. Lad, E.M. Incidence of Retinopathy of Prematurity in the United States: 1997 through 2005 / E.M. Lad, T. Hernandez-Boussard, J.M. Morton // Am. J. Ophthalmol. — 2009, Sep. — V.148. — №3. — P. 451–458.

10. Lee, J. Perinatal infection, inflammation, and retinopathy of prematurity / J. Lee, O. Dammann // Semin. Fetal. Neonatal. Med. — Feb., 2012. — V.17(1). — P. 26–29.

11. Micieli, J.A. A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity / J.A. Micieli, M. Surkont, A.F. Smith // Am. J. Ophthalmol. — 2009. — V.148. — №4. — P. 536–543.

12. Mintz-Hittner, Helen A. Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity / Helen A. Mintz-Hittner, Kathleen A. Kennedy, Alice Z. Chuang // N. Engl. J. Med. — 2011. — №364. — P. 603–615.

13. Vascular endothelial growth factor in eye disease / J.S. Penn [et al.] // Prog. Retin. Eye Res. — 2008. — №27. — P. 331–371.

14. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life / P. Sapieha [et al.] // J. Clin. Invest. — 2010. — V.120. — №9. — P. 3022–3032.

15. Semenza, G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level / G.L. Semenza // Physiology (Bethesda). — 2004. — №19. — P. 176–182.

16. West, H. Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes / H. West, W.D. Richardson, M. Fruttiger // Development. — 2005. — №132. — P. 1855–1862.


About this article

Author:

Year: 2014


Editor-in-chief
Sergey Aleksandrovich
MIROSHNIKOV

Crossref
Cyberleninka
Doi
Europeanlibrary
Googleacademy
scienceindex
worldcat
© Электронное периодическое издание: ВЕСТНИК ОГУ on-line (VESTNIK OSU on-line), ISSN on-line 1814-6465
Зарегистрировано в Федеральной службе по надзору в сфере связи, информационных технологий и массовых коммуникаций
Свидетельство о регистрации СМИ: Эл № ФС77-37678 от 29 сентября 2009 г.
Учредитель: Оренбургский государственный университет (ОГУ)
Главный редактор: С.А. Мирошников
Адрес редакции: 460018, г. Оренбург, проспект Победы, д. 13, к. 2335
Тел./факс: (3532)37-27-78 E-mail: vestnik@mail.osu.ru
1999–2021 © CIT OSU